INS37217 inhalation solution

INS37217 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INS37217 inhalation solution, covering 2015-01-29 to 2015-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [Phase 2]